Tuning the pH-sensitive cationic nanopolymers for in vitro release of doxorubicin DOI
Muhammad Usman Akram, Naseem Abbas, Muhammad Farman

et al.

International Journal of Polymeric Materials, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 9

Published: April 29, 2025

Language: Английский

A DFT study of pure and Si-decorated boron nitride allotrope Irida monolayer as an effective sensor for hydroxyurea drug DOI
Chou‐Yi Hsu, Mohammed H. Mohammed, Dharmesh Sur

et al.

Journal of Molecular Graphics and Modelling, Journal Year: 2025, Volume and Issue: 136, P. 108958 - 108958

Published: Jan. 22, 2025

Language: Английский

Citations

4

Hypoxia-inducible factor and cellular senescence in pulmonary aging and disease DOI Creative Commons
Riya Thapa,

Arockia Babu Marianesan,

Arcot Rekha

et al.

Biogerontology, Journal Year: 2025, Volume and Issue: 26(2)

Published: Feb. 26, 2025

Abstract Cellular senescence and hypoxia-inducible factor (HIF) signaling are crucial in pulmonary aging age-related lung diseases such as chronic obstructive disease idiopathic fibrosis cancer. HIF plays a pivotal role cellular adaptation to hypoxia, regulating processes like angiogenesis, metabolism, inflammation. Meanwhile, leads irreversible cell cycle arrest, triggering the senescence-associated secretory phenotype which contributes inflammation, tissue remodeling, fibrosis. Dysregulation of these pathways accelerates progression by promoting oxidative stress, mitochondrial dysfunction, epigenetic alterations. Recent studies indicate that interact at multiple levels, where can both induce suppress senescence, depending on conditions. While transient activation supports repair stress resistance, dysregulation exacerbates pathologies. Furthermore, emerging evidence suggests targeting could offer new therapeutic strategies mitigate diseases. This review explores intricate crosstalk between mechanisms, shedding light how their interplay influences progression. Additionally, we discuss potential interventions, including senolytic therapies modulators, enhance health longevity.

Language: Английский

Citations

2

Overcoming Obstacles: The Role of Lipid Nanocarriers in Therapeutic Approaches for Pancreatic Cancer DOI
Md Sadique Hussain, Bhupendra G. Prajapati, Sonu Gandhi

et al.

BioNanoScience, Journal Year: 2025, Volume and Issue: 15(2)

Published: March 11, 2025

Language: Английский

Citations

2

Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target DOI Creative Commons
Junaid Abid,

Basil A. Mahmood Al-Rawi,

Ahmad Mahmood

et al.

Hereditas, Journal Year: 2025, Volume and Issue: 162(1)

Published: March 24, 2025

Abstract Diffuse large B-cell lymphoma (DLBC) is the most common subtype of non-Hodgkin lymphoma, characterized by its aggressive nature and poor prognosis in advanced stages. Despite advances treatment, molecular mechanisms driving DLBC progression remain incompletely understood, necessitating identification novel biomarkers for diagnosis prognosis. In this study, we analyzed two publicly available datasets (GSE32018 GSE56315) from Gene Expression Omnibus database (GEO) to identify overlapping differentially expressed genes (DEGs). Later on, a comprehensive silico vitro methodology was adopted decipher role DEGs DLBC. analysis GSE32018 GSE56315 identified five gene: SP3, CSNK1A1, STYX, SIRT5, MGEA5. validation using GEPIA2 confirmed upregulation downregulation MGEA5 tissues compared normal controls. Furthermore, mutational revealed that CSNK1A1 only gene among these exhibit mutations, with 2.7% mutation frequency patients. Methylation highlighted negative correlation between methylation levels mRNA expression, while survival high STYX expression as significantly associated poorer overall Functional assays demonstrated knockdown U2932 cells led reduced cell proliferation, colony formation, enhanced wound healing, indicating STYX’s pivotal migration. Additionally, enrichment involvement key biological processes, including intracellular trafficking myeloid progenitor differentiation. These findings emphasize potential therapeutic targets DLBC, particularly highlighting promising prognostic marker target intervention.

Language: Английский

Citations

1

Gadolinium (Gd)-based nanostructures as dual-armoured materials for microbial therapy and cancer theranostics DOI
Nadhir N. A. Jafar, Junainah Abd Hamid, Farag M. A. Altalbawy

et al.

Journal of Microencapsulation, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 27

Published: Feb. 24, 2025

Gadolinium (Gd) nanoparticles hold significant promise in medical theranostics due to their unique properties. This review outlines the synthesis, characterisation, and applications of Gd nanostructures combating microbial threats advancing cancer theragnostic strategies. Synthesis methods such as co-precipitation, microemulsion, laser ablation are discussed, alongside TEM, SEM, magnetic characterisation. The antimicrobial efficacy nanostructures, potential combination therapy, promising anticancer mechanisms explored. Biocompatibility, toxicity, regulatory considerations also evaluated. Challenges, future perspectives, emerging trends nanostructure research highlighted, emphasising transformative applications.

Language: Английский

Citations

0

Advanced therapeutic strategies using Thermo-sensitive chitosan/pectin hydrogel in the treatment of multiple cancers DOI
Tosha Pandya,

Disha Joshi,

Zenab Presswala

et al.

Carbohydrate Polymers, Journal Year: 2025, Volume and Issue: 357, P. 123454 - 123454

Published: Feb. 27, 2025

Language: Английский

Citations

0

miR-210: A non-invasive biomarker for hypoxia-driven lung cancer diagnosis and therapy DOI
Ahsas Goyal, Muhammad Afzal,

Kavita Goyal

et al.

Clinica Chimica Acta, Journal Year: 2025, Volume and Issue: unknown, P. 120215 - 120215

Published: March 1, 2025

Language: Английский

Citations

0

Suzuki coupling reaction catalyzed by biosynthesized of gold nanoparticles in water under ultrasonic conditions and its application for treatment of bladder cancer DOI
Jing Liu, Li Guo

Journal of Organometallic Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 123597 - 123597

Published: March 1, 2025

Language: Английский

Citations

0

Neoadjuvant and Adjuvant Immunotherapy in the Treatment of Oral Squamous Cell Carcinoma DOI Open Access

Songlin Zhou,

Yutao Qin,

Anle Lei

et al.

Journal of Biochemical and Molecular Toxicology, Journal Year: 2025, Volume and Issue: 39(3)

Published: March 1, 2025

ABSTRACT Oral squamous cell carcinoma (OSCC) is experiencing a progressive increase in global incidence. Regrettably, this entity typically discovered at an advanced stage the majority of patients, which indicates increased therapeutic challenges and poorer prognosis. Programmed death protein 1 (PD‐1) appears to have significant role immunotherapy monoclonal antibodies targeting molecule been utilized as intervention. A decade research that neoadjuvant has garnered greater interest than adjuvant OSCC. This may be due serving preventive adjunctive treatment. Enhanced outcomes achieved by optimizing cancer microenvironment before surgery. Of note, introduced preoperatively for untreated

Language: Английский

Citations

0

Ultrasound-assisted biosynthesis of gelatin-gold nanocomposite: investigation of its antioxidant activity and its performance as anti-endometrial cancer in vitro DOI

Ying Shao,

Na Hu, Jun Zhang

et al.

Transition Metal Chemistry, Journal Year: 2025, Volume and Issue: unknown

Published: March 10, 2025

Language: Английский

Citations

0